Introduction {#sec0005}
============

Infection with *Brucella melitensis* is endemic to the Middle East and the eastern Mediterranean basin. It is colloquially known as the Malta fever in reference to the first cases reported in the medical literature \[[@bib0005]\]. Brucellosis is the most frequently encountered worldwide zoonotic disease \[[@bib0010],[@bib0015]\]. It usually presents as a systemic illness \[[@bib0020]\]. However, brucellosis has a wide spectrum of clinical presentations mimicking a number of infectious and non-infectious diseases. Several complications have been reported particularly related to osteoarticular and neuro-brucellosis \[[@bib0025],[@bib0030]\]. There have also been a few case reports on endocarditis, pacemaker infections and breast infections from different parts of the world, but not from Lebanon \[[@bib0035]\]. Here we report the unusual case of a simultaneous infection with *Brucella* species involving a cardiac pacemaker and the contralateral breast in a middle-aged woman from Lebanon with no significant previous medical problems.

Case presentation {#sec0010}
=================

A 52-year-old Lebanese woman presented to the emergency department of the American University of Beirut Medical Center (AUBMC) complaining of redness, pain and swelling at her pacemaker site on the upper left chest wall. The symptoms started one week earlier and had worsened over few days. She had no fever or chills that day. She was previously healthy except for an unclear history of an arrhythmia that occurred in 2005 necessitating the insertion of the cardiac pacemaker. The patient also complained of right breast pain, swelling and erythema of 3 days duration. Her primary care physician had prescribed amoxicillin-clavulanate for suspected mastitis. The patient also reported episodes of fever (temperature reaching 38.5 °C) and chills especially at nighttime for about three months prior to this current illness. She denied localizing signs or symptoms at the time.

On physical examination, the patient was hemodynamically stable and afebrile. Left chest wall erythema, induration and tenderness were observed. Erosion was noted at the skin overlying the pacemaker impulse generator and wires. The right breast was swollen, diffusely erythematous, and tender. No palpable masses were appreciated. The laboratory examination revealed a normal white Blood Cell count of 5400 per cu mm, (reference range: 4000--11000), polymorphonuclear cells were 50% (reference range: 40--65), and lymphocytes were 40% (reference range: 25--40). Her creatinine was 0.6 mg/dL (reference range: 0.5--1) but her C-reactive protein was elevated at 12.5 mg/dL (reference range: 0.0--2.5). A computed tomography scan of the chest wall with intravenous contrast revealed three well-circumscribed rim enhancing fluid collections in the right breast the largest measuring 1.9 × 2 cm. There was overlying skin thickening and associated subcentimetric right axillary lymph nodes. A collection on the left side of the chest wall over the site of the pacemaker was also noted.

On the second day of admission, the pacemaker impulse generator and wires were removed. Purulent drainage was noticed in the pacemaker bed and sent for culture. The Gram stain showed numerous WBCs but no microorganisms. The patient received intravenous teicoplanin and amoxicillin-clavulanate empirically awaiting the culture results. An ultrasound-guided aspiration of the right breast abscess was also performed. The content was sent for microbiologic culture as well and cytologic evaluation to rule out an underlying malignancy. On the 5th day of admission, cultures from both the pacemaker bed and the right breast grew *Brucella* species. The titers for the direct serum tube agglutination (STA) as well as the indirect test (*Brucella* Capt., Vircell, Spain) were both ≥ 1:1280. Two sets of blood cultures done on VIRTUO Biomerieux blood culture automated system were negative.

Upon further questioning, the patient remembered eating unpasteurized cheese several months before. She also remembered an episode of breast tenderness, swelling and warmth after that. The symptoms resolved spontaneously but were followed by a period of night sweats and low-grade fever.

The patient received intravenous gentamicin (240 mg intramuscularly daily) for two weeks along with rifampin (600 mg orally daily) and doxycycline (100 mg orally twice daily) for three months. At the end of her treatment, the patient reported marked improvement in her condition and complete resolution of the fever and chills. Four months later, the patient was asymptomatic, with normal physical examination. Repeat *Brucella* serology showed a decrease in the direct STA titer (1:320) and indirect *Brucella* titer (1:640). The repeated blood cultures were negative at 14 days of incubation and the breast ultrasound did not reveal a residual abscess.

Discussion {#sec0015}
==========

*Brucella* are small, non-encapsulated, non-motile, facultative intracellular, aerobic, Gram-negative coccobacilli \[[@bib0005],[@bib0040]\]. Brucellosis is almost invariably transmitted to humans from infected domestic animals and their contaminated products \[[@bib0045]\]. Infected animals excrete Brucellae in the urine, milk, placenta, and other products of miscarriages. In this way, the bacteria are disseminated and infect other animals and humans \[[@bib0050]\]. *Brucella* organisms can survive up to two days in milk at 8 °C, up to three weeks in frozen meat, and up to three months in goat cheese \[[@bib0050],[@bib0055]\]. Even though a wide range of clinical manifestations and complications have been reported, only few reports describe *Brucella* breast infections or pacemaker infections, mainly from countries of the Mediterranean basin \[[@bib0015]\].

*Brucella* breast infections were mainly reported in women with a wide age distribution \[[@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080]\]. It is most likely due to hematogenous spread, as both breasts have been involved simultaneously. There were no associated underlying malignancies. Drainage culture was required to establish the diagnosis \[[@bib0065],[@bib0075],[@bib0085]\]. Blood cultures were not all positive \[[@bib0070],[@bib0075]\]. *Brucella* serology was reported positive in one case most likely due to relying on direct agglutination test only and not using more sensitive tests such as the indirect titers, *Brucella* CAPT or ELISA \[[@bib0040],[@bib0065]\] ([Table 1](#tbl0005){ref-type="table"}).Table 1Breast infections with brucellosis.Table 1Study/yearPatient/age*Brucella* preceding and associated infections*Brucella* blood cultureMiscellaneous culturesAntimicrobialsTreatment durationcountryGasser et al. \[[@bib0080]\]52 year old womanAcute presentation with uveitisNoAbscess cultureDoxycycline\
streptomycin45 days\
15 daysSpainAl Abdely et al. \[[@bib0060]\]39-year-old /womanNo informationN/ABreast abscessDoxycycline & TMP/SMX3 monthsSaudi ArabiaTsironi et al. \[[@bib0065]\]77 year old/womanYes, acute illness 5 daysNoBreast abscessDoxycycline & streptomycin (1st infection)8 weeks\
3 weeksGreeceErdem et al.63-year-old femaleNo informationNoBreast abscessTetracycline & rifampin1 yearTurkeyGurleyik et al. \[[@bib0085]\]46 year old woman3 months acute illness and spinal (L5-S1) abscessNoNegative spinal and breast abscess cultureTMP-SMX\
Later\
Streptomycin\
Rifampin + tetracycline2 weeks\
4 monthsTurkeyAkay et al.52-year old womanNo informationNoNoneRifampin 600 mg/day and doxycycline 200 mg/day8 weeksTurkeyIbis et al. \[[@bib0070]\]48 year old/man2 years night sweats. Bilateral breasts.NoAbscess culture positiveDoxycycline & rifampinNot specifiedTurkeyNemenqani et al. \[[@bib0075]\]6 cases womenSaudi ArabiaWith permission45 year old womanBilateral abscesses three weeksN/AN/ARifampin & Tetracycline7 weeks35 year old womanL breast abscess. Systemic illness precedingSurgical drainage & AntimicrobialsN/AN/A20 year old womanR breast abscessN/ATMP / SMX2 months32 year old womanBreast AbscessN/ASurgical drainage & AntimicrobialsN/A48 year old womanL breast abscessN/AN/ADoxycycline and StreptomycinN/A32 year old womanLeft Breast abscessN/AN/ARifampin & TetracyclineN/A

Symptoms may last for several weeks before the diagnosis of *Brucella* mastitis is established if there are no associated systemic manifestations. In 1991, Gasser et al. reported a case of *Brucella* mastitis and posterior uveitis that improved markedly on antimicrobial treatment \[[@bib0080]\]. Failure of treatment response with first line antimicrobials used for common causes of cellulitis and skin and soft tissue infection should prompt suspicion of infection with *Brucella* in the correct endemic context \[[@bib0060]\]. Subsequently, successful response was achieved in patients receiving doxycycline and trimethoprim-sulfamethoxazole doxycycline and streptomycin \[[@bib0065]\] or doxycycline and rifampin \[[@bib0070]\] ([Table 1](#tbl0005){ref-type="table"}).

*Brucella* pacemaker infection is also a rare entity with only few reported cases in the literature ([Table 2](#tbl0010){ref-type="table"}). In 2013, a study by Osmonov et al. focused on cardiac-device related endocarditis (CDE) in one large hospital in Turkey. One of 23 cardiac devices infection was caused by *B*. *melitenis* \[[@bib0090]\]. Similarly, in 2014, a study by Simsek-Yavuz et al. looking at infective endocarditis in 325 cases in Turkey revealed one case of CDE infection due to *B*. *melitensis*. No information was found in the article on the patients' characteristics, treatment, and prognosis \[[@bib0095]\]. In our review of published cases ([Table 2](#tbl0010){ref-type="table"}), all of patients were men; the age range was 38-71 years, with the mean of 61.8 years. The pacemaker had been inserted for a mean of 7 years (duration range from 2 to 20 years) for various cardiac indications. Several of these men had direct occupational contact with sheep \[[@bib0100],[@bib0105]\].Table 2case reports of brucellosis involving pacemakers and cardiac devices.Table 2Study/yearPatient/agePacemaker type of device and time since implantation*Brucella* preceding*Brucella* blood cultureMiscellaneous culturesPacemaker and leads removedAntimicrobialsTreatment durationcountryDe la Fuente et al. \[[@bib0105]\]63-year-old /man2 yearsYes, one year precedingNoPacemaker, leads, pus, necrotic tissueYesDoxycycline & rifampin\
Streptomycin45 days\
21 daysSpainFrancia et al. \[[@bib0125]\]71 year old/man5 yearsYes, based on positive serology\
Sacroilitis 2 months later\
And two recurrencesNoPacemaker and leads. No obvious signs on exam. Negative TEE.YesDoxycycline & streptomycin (1^st^ infection)\
Doxycycline & Rifampin (2^nd^ infection)6 weeks\
8 weeksSpainUlkar et al. \[[@bib0115]\]68 year old/man1 year (patient had previous pacemaker for 7 years)NoYes, positiveAbscess culture positiveYesDoxycycline & rifampin6 weeksTurkeyMiragliotta et al. \[[@bib0110]\]No informationNo informationYes, relapsedNo informationNo informationNo informationNo informationNo informationItalyDourakis et al. \[[@bib0100]\]70 year old/man7 yearsYes, 25 years prior to presentationYes positiveTEE showed mass on tricuspid,\
Pacemaker and leads had vegetationYesDoxycycline, Ciprofloxacin & Rifampin12 monthsGreeceAl-Majid et al. \[[@bib0130]\]38 year old/man20 years/pacemakerRelapsing *brucella* three times in one yearYes positiveYes leads positiveLeads removedDoxycycline & Rifampin6 weeksSaudi ArabiaGungor et al. \[[@bib0120]\]61 year old2 years PacemakerNoYesSkin abscessYesDoxycycline & Rifampin6 weeksTurkeyOsmonov et al. \[[@bib0090]\]NA6 months pacemakerNAYes positiveYes leads positive\
Echocardiography positiveLeads and pacemaker removedNANATurkey

Eradication of the infection and complete resolution are possible only after complete extraction of the device and leads \[[@bib0110]\]. In some instances, the *Brucella* infection presented as device infection. The first case of *B*. *melitensis* pacemaker infection was reported by de la Fuente et al. in 1997 in a 63-year-old sheep herder who initially had a pacemaker implanted in 1994 who developed *B*. *melitensis* pacemaker infection \[[@bib0105]\]. Similarly, other patients developed *B. melitensis* infection months or years after the implantation of a cardiac device, presumably leading to the seeding of the device with the organism \[[@bib0100],[@bib0105],[@bib0115]\]. Cardiomyopathy, valvular vegetation and abscess formation at the pacemaker site were described in those instances. Treatment included antimicrobials and removal of the pacemaker or defibrillator and leads. *B. melitensis* pacemaker infection presented as recurrent skin papules at the site of the device in one report \[[@bib0120]\]. Two years after the first onset of the lesions, the pacemaker was removed. In other cases, patients suffered recurrent systemic *Brucella* infections several years after the implantation of the cardiac devices, suggesting that those organisms have the potential to seed the cardiac device at any point after implantation and establish a focus for recurrent episodes \[[@bib0125],[@bib0130]\]. It took several recurrences of the illness before the extraction of the device and leads. In one case the transesophageal echocardiography was negative for endocarditis, yet the pacemaker leads were removed despite lack of infectious signs \[[@bib0125]\]. Culture of the leads is usually positive for *B*. *melitensis*.

The present case is the first concomitant mastitis and pacemaker infection with brucellosis. There are only six cases of *Brucella* breast abscesses in the literature, only eight case reports of pacemaker endocarditis. Our case, as in other cases, highlights the insidious nature of this infection. Such findings reflect the importance of awareness about the disease in endemic areas to establish early diagnosis and treatment and avoid serious complications.

In this report, we emphasize the role of brucellosis in complicated infections especially that this disease remains endemic to the Middle East and East Mediterranean basin. *Brucella* infection can have a myriad of clinical presentations; prolonged undulating fever and night sweats comprise the most classical signs and symptoms, usually lasting days to weeks before recognition \[[@bib0020]\]. Complications of *Brucella* infection are varied and include orchitis and/or epididymitis, spondylitis and osteoarticular involvement, endocarditis, myocarditis, endarteritis, uveitis, central nervous system infection, as well as less frequently hepatitis, pneumonitis, or splenic abscess \[[@bib0030]\]. Such complications are preceded by a bacteremic phase and hematogenous seeding of an organ. Those organs usually serve as a focus and lead to the recurrences and relapses witnessed by patients \[[@bib0135]\]. Inflammation of those organs is the only clinical manifestation of ongoing infection with *Brucella* in the absence of other systemic symptoms. In our patient and after the initial infection, fever and night sweats resolved spontaneously and she remained asymptomatic for several weeks before presenting with the dramatic erosion at the pacemaker site. A certain threshold of suspicion for *Brucella* infection should be kept even for usual presentations in the right geographic context.

In our patient, the infection was most likely acquired after ingestion of unpasteurized cheese; she likely developed a bacteremia and seeded the breast area since the pacemaker abscess was noted after the development of the breast abscess. This suggests that the breast abscess served as a nidus for the infection to later spread hematogenously and colonize the pacemaker leads. Clumping development is a complex process that is initiated when bacteria attach to a surface using exopolysaccharide polymers or other adhesins and develop into microcolonies. Because bacterial clumping is one of the initial steps of biofilm formation, the clumping phenotype in *B. melitensis* was described giving evidence that this alpha-proteobacterium could form biofilms during its lifecycle and cause hardware infection \[[@bib0140]\].

Treating and managing such infections entails the drainage of the breast abscesses, removal of the pacemaker and its leads and a prolonged course of antimicrobials. In our case, and as reported in the literature, the pacemaker and leads were extracted for this patient. *Brucella* cardiac device endocarditis is a relapsing disease if the leads and pacemaker are not extracted, together with a prolonged treatment with antimicrobials. The insidious presentations and complications of *Brucella* infections remain a major diagnostic challenge. Infections with brucellosis should figure in the differential diagnosis of complicated infections, as noted in this rare case of simultaneous infection of breast and pacemaker device, especially in endemic areas.

Author statement {#sec0020}
================

All authors contributed to the conceptualization and preparation of this manuscript.

Dima Ibrahim and Helene Dabbous contributed equally

Dima Ibrahim: Writing: original draft and tables

Helene Dabbous: Writing: original draft and tables

Yasmina Abi-Aad: Writing: original draft and review

George Araj: Writing: review and editing

Nesrine Rizk: Writing -- review & editing

^Disclosure^ {#sec0025}
============

^Authors\ declare\ no\ conflict\ of\ interest^.

^No\ financial\ support\ was\ needed\ to\ write\ the\ review.^

[^1]: Contributed equally to this manuscript
